As a paediatrician with special interest in infectious disease epidemiology and public health, Dr. Quique Bassat combines his clinical work with biomedical research and worldwide results dissemination of those diseases that most affect the poor and vulnerable. He is an ICREA Research Professor and Head of the Malaria Programme at the Barcelona Institute for Global Health (ISGlobal).
His contribution has been key in the Bill and Melinda Gates Foundation funded development and validation of anti-malarial drugs as well as in Pian eradication in Sub-Saharan Africa. He also pioneers in the use of minimally-invasive techniques in post-mortem analysis for the identification of the cause of death in resource-constrained regions.
Quique is a distinguished expert in his fields of research and practice, having published over 450 scientific articles in international peer-reviewed journals, as well as about 25 book chapters.
He recently was granted the “Medalla Narcís Monturiol”, Catalonia’s highest scientific research achievement . As a result of the COVID-19 pandemic, he has been involved in different studies and trials to better understand the use of preventive and therapeutic strategies for COVID-19, as well as the particularities of SARS-CoV-2 infection and disease in children, and advised the Spanish Government on topics related to Pediatric COVID-19.
Quique has been appointed General Director of ISGlobal from January 2024.
It is our privilege, to have him leading the clinical validation studies in Manhiça (Mozambique) and Rabat (Morroco) and defining user design requirements of our solutions in low-and middle-income clinical settings.